anti–pd-1 adjuvant therapy in melanoma
Published 5 years ago • 305 plays • Length 8:01Download video MP4
Download video MP3
Similar videos
-
2:40
dr. eggermont on the impact of adjuvant anti–pd-1 agents in melanoma
-
4:29
anti–pd-1 therapy in metastatic melanoma
-
8:47
adjuvant therapy in melanoma: targeted vs immuno-oncology
-
6:23
adjuvant therapy options in melanoma treatment
-
4:01
adjuvant pd-(l)1 inhibitors for melanoma
-
5:54
adjuvant therapy in melanoma: safety and efficacy
-
4:12
adjuvant therapy in melanoma: combi-ad trial
-
2:31
insights from the nadina and prado trials for in late stage melanoma
-
6:04
using adjuvant therapy in patients with melanoma
-
7:03
adjuvant therapy for melanoma
-
4:14
adjuvant therapy for melanoma: novel treatment options
-
3:20
considerations surrounding adjuvant therapy in melanoma
-
1:10
dr. luke on adjuvant therapies in development for melanoma
-
5:57
adjuvant ipilimumab in high-risk melanoma
-
4:59
adjuvant therapy options in melanoma
-
9:23
managing recurrence after adjuvant therapy in melanoma
-
2:06
dr. tarhini discusses adjuvant therapy for melanoma
-
5:43
role of adjuvant radiation therapy in melanoma
-
1:43
dr. topalian on biomarkers for anti- pd-1 therapies in melanoma